18 November 2017
News and Views
Links and Services
A study in the latest issue of the Alimentary Pharmacology & Therapeutics investigates the risk of hyperhomocysteinemia in inflammatory bowel diseases.
The magnitude of association between homocysteine metabolism and inflammatory bowel diseases (IBD
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors